glycopyrrolate
Generic: glycopyrrolate
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
glycopyrrolate
Generic Name
glycopyrrolate
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION
Routes
Active Ingredients
glycopyrrolate .2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
76045-023
Product ID
76045-023_1925138e-94b7-4e29-815e-f6681943a734
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA214919
Listing Expiration
2026-12-31
Marketing Start
2022-04-21
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76045023
Hyphenated Format
76045-023
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
glycopyrrolate (source: ndc)
Generic Name
glycopyrrolate (source: ndc)
Application Number
NDA214919 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .2 mg/mL
Packaging
- 10 SYRINGE in 1 CARTON (76045-023-30) / 3 mL in 1 SYRINGE (76045-023-00)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "1925138e-94b7-4e29-815e-f6681943a734", "openfda": {"unii": ["V92SO9WP2I"], "rxcui": ["2473383"], "spl_set_id": ["685aaf64-1a64-42f9-a96f-4764d650c26f"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 SYRINGE in 1 CARTON (76045-023-30) / 3 mL in 1 SYRINGE (76045-023-00)", "package_ndc": "76045-023-30", "marketing_start_date": "20220421"}], "brand_name": "Glycopyrrolate", "product_id": "76045-023_1925138e-94b7-4e29-815e-f6681943a734", "dosage_form": "INJECTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "76045-023", "generic_name": "Glycopyrrolate", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Glycopyrrolate", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": ".2 mg/mL"}], "application_number": "NDA214919", "marketing_category": "NDA", "marketing_start_date": "20220421", "listing_expiration_date": "20261231"}